NantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive Team
23 Avril 2024 - 3:00PM
Business Wire
NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the
appointment of Marc Harrison as Chief Legal Officer, further
strengthening its executive team.
Marc Harrison joined NantHealth in February 2024, bringing over
30 years of legal experience, including 24 years focused on public
and private companies within the healthcare, pharmaceutical, and
biotechnology industries. Prior to joining NantHealth, Marc served
as the chief legal and compliance officer at Legend Biotech, a
publicly traded biotechnology company, and served in a similar role
at Breckenridge Pharmaceutical, a privately held pharmaceutical
company.
With a background that includes executive leadership, team
building, and handling complex corporate, licensing, and commercial
transactions, Marc has demonstrated a keen ability to navigate
healthcare’s complex regulatory and compliance landscape. His prior
leadership positions with both public and private companies,
uniquely positions him to contribute strategic insight to
NantHealth's legal operations.
"Marc’s appointment to our executive team signifies a pivotal
milestone in NantHealth's evolution. As our company continues to
grow, our legal team's role becomes increasingly vital. With Marc's
seasoned expertise and robust background, we're confident in our
ability to navigate complex legal landscapes," remarked Dr. Haris
Naseem, Chief Executive Officer at NantHealth. "His extensive
experience and unwavering dedication to advancing healthcare
solutions align seamlessly with our mission to drive innovation and
enhance patient outcomes."
With a distinguished track record of leadership and a penchant
for fostering collaborative environments, Marc is poised to play a
pivotal role in guiding NantHealth's legal strategies. His
commitment to championing initiatives that enhance healthcare
accessibility and efficiency underscores NantHealth's unwavering
dedication to transformative change in the industry.
In his new role, Marc will collaborate closely with NantHealth's
leadership team to further elevate the company's legal capabilities
and drive forward its strategic vision. He will be involved in all
facets of Eviti Connect®, NaviNet®, OpenNMS and NantHealth’s
affiliated company, AirStrip®.
Marc holds a Bachelor of Arts degree from Emory University and a
Juris Doctor from New York University School of Law.
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies,
provides enterprise solutions that help businesses transform
complex data into actionable insights. By offering efficient ways
to move, interpret and visualize complex and highly sensitive
information, NantHealth enables customers in healthcare, life
sciences, logistics, telecommunications and other industries to
automate, understand and act on data while keeping it secure and
scalable. NantHealth’s product portfolio comprises the latest
technology in payer-provider collaboration platforms for real-time
coverage, decision support and data solutions that provide
multi-data analysis, reporting and professional services offerings.
For more information, visit nanthealth.com, follow us on Twitter,
Facebook, LinkedIn and YouTube and subscribe to our blog.
Forward Looking Statements
This news release contains certain statements of a
forward-looking nature relating to future events or future business
performance. Forward-looking statements can be identified by the
words “expects,” “anticipates,” “believes,” “intends,” “estimates,”
“plans,” “will,” “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. Risks and uncertainties include, but are not limited to,
statements regarding the timing and effectiveness of the reverse
stock split and the Company’s ability to maintain its listing on
Nasdaq (including its ability to achieve or maintain the minimum
bid price required by Nasdaq and to comply with other requirements
for listing on Nasdaq). Such forward-looking statements are not
meant to predict or guarantee actual results, performance, events
or circumstances and may not be realized because they are based
upon the Company’s current plans, objectives, beliefs,
expectations, and assumptions and are subject to a number of risks
and uncertainties and other influences, many of which the Company
has no control over. Actual results and the timing of certain
events and circumstances may differ materially from those described
by the forward-looking statements as a result of these risks and
uncertainties. Factors that may influence or contribute to the
inaccuracy of the forward-looking statements or cause actual
results to differ materially from expected or desired results may
include, without limitation, the price and volume fluctuations in
trading of the Company’s Common Stock, the potential adverse effect
of the reduced number of shares outstanding following the reverse
stock split on the liquidity of the Company’s Common Stock,
potentially adverse Nasdaq decisions related to the listing of the
Company’s Common Stock on the Nasdaq Capital Market. The Company
undertakes no obligation to update any forward-looking statement in
light of new information or future events, except as otherwise
required by law. Forward-looking statements involve inherent risks
and uncertainties, most of which are difficult to predict and are
generally beyond our control. Actual results or outcomes may differ
materially from those implied by the forward-looking statements as
a result of the impact of a number of factors, many of which are
discussed in more detail in our reports filed with the Securities
and Exchange Commission.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240423259598/en/
Jen Hodson NantWorks 562-397-3639 jen@nant.com
NantHealth (NASDAQ:NH)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
NantHealth (NASDAQ:NH)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024